Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province

Eastern Mediterranean Health Journal

Volumn 13, Issue 2, 2007, Pages 250-256

  Mohtasham Amiri, Z ^a   Rezvani, M ^a   Jafari Shakib, R ^a   Jafari Shakib, A ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PREVALENCE; PRISONER; RISK FACTOR; TATTOO;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HARM REDUCTION; HEPATITIS ANTIBODIES; HEPATITIS C; HUMANS; IRAN; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PRISONERS; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TATTOOING;

EID: 34447293284     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alter HJ et al. Hepatitis C in asymptomatic blood donors. Hepatology, 1997, 26 (Suppl. 1):295-33S.
2. Alter MJ. Hepatitis C virus infection in the United States. Journal of hepatology, 1999, 31(Suppl. 1):88-91.
3. Williams I. Epidemiology of hepatitis C in the United States. American journal of medicine, 1999, 107:25-9S.
4. Samuel MC et al. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiology and infection, 2001, 127:475-84.
5. El-Fatih Idris A et al. Drug use among prisoners in three main prisons in Khartoum, Sudan. Eastern Mediterranean health journal, 1998, 4(1):122-7.
6. Massad E et al. Seroprevalence of HIV, HCV and syphilis in Brazilian preponderance of parenteral transmission. European journal of epidemiology, 1999, 15:439-45.
7. Long J et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. British medical journal, 2001, 323(7323):1209-14.
8. Gill O, Noone A, Heptonstall J. Imprisonment, injecting drug use, and bloodborne viruses. British medical journal, 1995, 310:275-6.
9. Taylor A et al. Transmission of HIV in prison: evidence of risk. British medical journal, 1993, 307:623.
10. Covell RG et al. Prison experience of injecting drug users in Glasgow. Drug and alcohol dependence, 1993, 32:9-14.
11. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. American Journal of public health, 2002, 92(11):1789-95.
12. Crofts N et al. Spread of bloodborne viruses among Australian prison entrants. British medical journal, 1995, 310:285-8.
13. Butler T et al. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners, NSW, 1996. Australian and New Zealand journal of public health, 1999, 23(4):377-84.
14. Gore SM et al. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviors. Quarterly journal of medicine, 1999, 92:25-32.
15. Stark K et al. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection among injecting drug users in Berlin. International journal of epidemiology, 1997, 26(6):1359-66.
16. Thorpe LE et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American journal of epidemiology, 2002, 155(7):645-53.
17. Ford PM, Pearson M, Sankar-Mistry P. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Quarterly journal of medicine, 2000, 93:113-9.
18. Weild AR et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Communicable disease and public health, 2000, 3(2):121-6.
19. Malliori M et al. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction, 1998, 93:243-51.
20. Penny CA et al. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction, 2001,96:1787-97.
21. Saha MK et al. Prevalence of HCV and HBV infection amongst HIV seropositive intravenous drug users and their non-injecting wives in Manipur, India. Indian journal of medical research, 2000, 111:37-9.
22. Gyarmathy VA et al. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. Journal of acquired immune deficiency syndromes, 2002, 30(4):448-56.
23. Gates JA et al. Risk Factors for hepatitis c infection and perception of antibody status among male prison inmates in the hepatitis c incidence and transmission in prisons study cohort, Australia. Journal of urban health, 2004, 81(3):448-52.
24. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and hemodialysis patients in north Iran, Rasht. Journal of viral hepatitis, 2002, 9(5):390-2.
25. Abildgaard N, Peterslund NA. Hepatitis C virus transmitted by tattooing needle. Lancet, 1991, 338:460.